Pyramid Pharma Services Announces Drug Product Manufacturing Agreement for Phio Pharmaceuticals’ Lead Oncology Candidate, PH-762
Advancing U.S.-based cGMP manufacturing to support clinical and future commercial objectives of a novel siRNA therapy for skin cancers Costa